Personal Information
Organización/Lugar de trabajo
San Francisco Bay Area United States
Ocupación
Managing Partner, SunilM1
Sector
Technology / Software / Internet
Sitio web
http://www.monetasuite.com
Acerca de
Summary of Achievements:
1982 - Came to USA at 22 with $100 and letter guaranteeing full scholarship to Brandeis.
1985 - Achieved black belt in karate (shotokan). University team captain.
1986 - Received Ph.D. in Biophysics (4th degree) in 4 years. Thesis published on cover of Nature.
1993 - Helped create humanized antibody (Campath) at OXMOL (Employee no. 3). Company floated on LSO with $500MM valuation.
1995 - Helped take first drug design company public (NASDAQ:TRPS).
1996 - Published "Molecular Biotechnology" (J.Wiley). Over 4000 copies sold.
1998 – Used rational drug design to develop COX-2 inhibitors (“super aspirins”) while heading bioinformatics at Roche Bioscience.
2001-...
Etiquetas
design
innovation
user experience
habits
product design
behavior
neuroscience
ideation
disruption
brainstorm
technology
enterprise
digital strategy
work2.0
workshop
transformation
organizational change
mobile
behavior change
product development
scale
marketing
habit
startup company
silicon valley
Ver más
Presentaciones
(6)Recomendaciones
(1)HK-SCC::SmarterCITIES? ... better choices! ZCB-8jun17
stanley2curtis
•
Hace 6 años
Personal Information
Organización/Lugar de trabajo
San Francisco Bay Area United States
Ocupación
Managing Partner, SunilM1
Sector
Technology / Software / Internet
Sitio web
http://www.monetasuite.com
Acerca de
Summary of Achievements:
1982 - Came to USA at 22 with $100 and letter guaranteeing full scholarship to Brandeis.
1985 - Achieved black belt in karate (shotokan). University team captain.
1986 - Received Ph.D. in Biophysics (4th degree) in 4 years. Thesis published on cover of Nature.
1993 - Helped create humanized antibody (Campath) at OXMOL (Employee no. 3). Company floated on LSO with $500MM valuation.
1995 - Helped take first drug design company public (NASDAQ:TRPS).
1996 - Published "Molecular Biotechnology" (J.Wiley). Over 4000 copies sold.
1998 – Used rational drug design to develop COX-2 inhibitors (“super aspirins”) while heading bioinformatics at Roche Bioscience.
2001-...
Etiquetas
design
innovation
user experience
habits
product design
behavior
neuroscience
ideation
disruption
brainstorm
technology
enterprise
digital strategy
work2.0
workshop
transformation
organizational change
mobile
behavior change
product development
scale
marketing
habit
startup company
silicon valley
Ver más